118 related articles for article (PubMed ID: 2426623)
1. Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
Koike K; Judd AM; Login IS; Yasumoto T; MacLeod RM
Neuroendocrinology; 1986; 43(3):283-90. PubMed ID: 2426623
[TBL] [Abstract][Full Text] [Related]
2. A possible role of arachidonate metabolism in the mechanism of prolactin release.
Judd AM; Koike K; MacLeod RM
Am J Physiol; 1986 Mar; 250(3 Pt 1):E288-95. PubMed ID: 2420203
[TBL] [Abstract][Full Text] [Related]
3. Dopamine decreases 7315a tumor cell prolactin release induced by calcium mobilization.
Judd AM; Koike K; Schettini G; Login IS; Hewlett EL; Yasumoto T; MacLeod RM
Endocrinology; 1985 Sep; 117(3):1215-21. PubMed ID: 3926467
[TBL] [Abstract][Full Text] [Related]
4. Nafazatrom, an arachidonate metabolism inhibitor, decreases prolactin and GH release.
Judd AM; Login IS; Ehreth JT; MacLeod RM
Eur J Pharmacol; 1986 Sep; 128(3):151-6. PubMed ID: 3792440
[TBL] [Abstract][Full Text] [Related]
5. Dopamine inhibits calcium flux in the 7315a prolactin-secreting pituitary tumour.
Login IS; Judd AM; Macleod RM
Cell Calcium; 1988 Feb; 9(1):27-31. PubMed ID: 3359479
[TBL] [Abstract][Full Text] [Related]
6. The effects of maitotoxin on 45Ca2+ flux and hormone release in GH3 rat pituitary cells.
Login IS; Judd AM; Cronin MJ; Koike K; Schettini G; Yasumoto T; MacLeod RM
Endocrinology; 1985 Feb; 116(2):622-7. PubMed ID: 2578383
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha increases release of arachidonate and prolactin from rat anterior pituitary cells.
Koike K; Hirota K; Ohmichi M; Kadowaki K; Ikegami H; Yamaguchi M; Miyake A; Tanizawa O
Endocrinology; 1991 Jun; 128(6):2791-8. PubMed ID: 1903696
[TBL] [Abstract][Full Text] [Related]
8. Arachidonate stimulates prolactin release in vitro: a role for the fatty acid and its metabolites as intracellular regulator(s) in mammotrophs.
Canonico PL; Judd AM; Koike K; Valdenegro CA; MacLeod RM
Endocrinology; 1985 Jan; 116(1):218-25. PubMed ID: 2981065
[TBL] [Abstract][Full Text] [Related]
9. Dopamine inhibits maitotoxin-stimulated pituitary 45Ca2+ efflux and prolactin release.
Login IS; Judd AM; MacLeod RM
Am J Physiol; 1986 Jun; 250(6 Pt 1):E731-5. PubMed ID: 3717333
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
[TBL] [Abstract][Full Text] [Related]
11. A possible role for lipoxygenase and epoxygenase arachidonate metabolites in prolactin release from pituitary cells.
Judd AM; Spangelo BL; Ehreth JT; MacLeod RM
Neuroendocrinology; 1988 Oct; 48(4):407-16. PubMed ID: 3145470
[TBL] [Abstract][Full Text] [Related]
12. Maitotoxin: effects on calcium channels, phosphoinositide breakdown, and arachidonate release in pheochromocytoma PC12 cells.
Choi OH; Padgett WL; Nishizawa Y; Gusovsky F; Yasumoto T; Daly JW
Mol Pharmacol; 1990 Feb; 37(2):222-30. PubMed ID: 2154671
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.
Judd AM; Login IS; Kovacs K; Ross PC; Spangelo BL; Jarvis WD; MacLeod RM
Endocrinology; 1988 Nov; 123(5):2341-50. PubMed ID: 2844508
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid metabolism and casein secretion in lactating rabbit mammary epithelial cells: effects of inhibitors of prostaglandins and leukotrienes synthesis.
Blachier F; Lacroix MC; Ahmed AM; Léger C; Ollivier-Bousquet M
Prostaglandins; 1988 Feb; 35(2):259-76. PubMed ID: 2834771
[TBL] [Abstract][Full Text] [Related]
15. Pertussis toxin pretreatment abolishes dihydropyridine inhibition of calcium flux in the 235-1 pituitary cell line.
Schettini G; Meucci O; Florio T; Grimaldi M; Landolfi E; Magri G; Yasumoto T
Biochem Biophys Res Commun; 1988 Feb; 151(1):361-9. PubMed ID: 2450538
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic inhibition of anterior pituitary adenylate cyclase activity and prolactin release: the effects of perturbing calcium on catalytic adenylate cyclase activity.
Schettini G; Hewlett EL; Cronin MJ; Koike K; Yasumoto T; MacLeod RM
Neuroendocrinology; 1986; 44(1):1-7. PubMed ID: 3024052
[TBL] [Abstract][Full Text] [Related]
17. Bile salt stimulation of colonic epithelial proliferation. Evidence for involvement of lipoxygenase products.
DeRubertis FR; Craven PA; Saito R
J Clin Invest; 1984 Nov; 74(5):1614-24. PubMed ID: 6438153
[TBL] [Abstract][Full Text] [Related]
18. Role of arachidonate metabolism on the in vitro release of luteinizing hormone and prolactin from the anterior pituitary gland: possible involvement of lipoxygenase pathway.
Conte D; Falaschi P; Proietti A; D'Urso R; Citarella F; Nordio M; Romanelli F; Maggi R; Motta M; Isidori A
Neuroendocrinology; 1986; 43(3):428-34. PubMed ID: 3090467
[TBL] [Abstract][Full Text] [Related]
19. Involvement of arachidonate metabolism in neurotensin-induced prolactin release in vitro.
Canonico PL; Speciale C; Sortino MA; Scapagnini U
Am J Physiol; 1985 Sep; 249(3 Pt 1):E257-63. PubMed ID: 3929616
[TBL] [Abstract][Full Text] [Related]
20. Reserpine is a calcium channel antagonist in normal and GH3 rat pituitary cells.
Login IS; Judd AM; Cronin MJ; Yasumoto T; MacLeod RM
Am J Physiol; 1985 Jan; 248(1 Pt 1):E15-9. PubMed ID: 2578255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
